These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 23747423)

  • 1. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42.
    Izuo N; Kume T; Sato M; Murakami K; Irie K; Izumi Y; Akaike A
    ACS Chem Neurosci; 2012 Sep; 3(9):674-81. PubMed ID: 23019494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
    Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
    Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of physiological and toxic conformations in Abeta42 aggregates.
    Masuda Y; Uemura S; Ohashi R; Nakanishi A; Takegoshi K; Shimizu T; Shirasawa T; Irie K
    Chembiochem; 2009 Jan; 10(2):287-95. PubMed ID: 19115328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23.
    Murakami K; Horikoshi-Sakuraba Y; Murata N; Noda Y; Masuda Y; Kinoshita N; Hatsuta H; Murayama S; Shirasawa T; Shimizu T; Irie K
    ACS Chem Neurosci; 2010 Nov; 1(11):747-56. PubMed ID: 22778811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Models of Quasi-Stable Amyloid β40 Oligomers with Significant Neurotoxicity.
    Irie Y; Murakami K; Hanaki M; Hanaki Y; Suzuki T; Monobe Y; Takai T; Akagi KI; Kawase T; Hirose K; Irie K
    ACS Chem Neurosci; 2017 Apr; 8(4):807-816. PubMed ID: 28026168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic and Biophysical Studies on the Toxic Conformer in Amyloid β with the E22Δ Mutation in Alzheimer Pathology.
    Murakami K; Yamaguchi T; Izuo N; Kume T; Hara H; Irie K
    ACS Chem Neurosci; 2020 Oct; 11(19):3017-3024. PubMed ID: 32790274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
    Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
    J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity.
    Jin L; Wu WH; Li QY; Zhao YF; Li YM
    Nanoscale; 2011 Nov; 3(11):4746-51. PubMed ID: 21952557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease.
    Murakami K; Masuda Y; Shirasawa T; Shimizu T; Irie K
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S169-79. PubMed ID: 20590832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death.
    Kanno H; Kawakami Z; Iizuka S; Tabuchi M; Mizoguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2013 Aug; 149(1):360-70. PubMed ID: 23838475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of the amyloid β40 dimer model with a linker at position 30 adjacent to the intermolecular β-sheet region.
    Murakami K; Suzuki T; Hanaki M; Monobe Y; Akagi K; Irie K
    Biochem Biophys Res Commun; 2015 Oct; 466(3):463-7. PubMed ID: 26367176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Toxic Conformer of Aβ42 with a Turn at 22-23 is a Novel Therapeutic Target for Alzheimer's Disease.
    Izuo N; Kasahara C; Murakami K; Kume T; Maeda M; Irie K; Yokote K; Shimizu T
    Sci Rep; 2017 Sep; 7(1):11811. PubMed ID: 28924167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies bound to Aβ oligomers potentiate the neurotoxicity of Aβ by activating microglia.
    Morkuniene R; Zvirbliene A; Dalgediene I; Cizas P; Jankeviciute S; Baliutyte G; Jokubka R; Jankunec M; Valincius G; Borutaite V
    J Neurochem; 2013 Sep; 126(5):604-15. PubMed ID: 23745639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model.
    Krantic S; Isorce N; Mechawar N; Davoli MA; Vignault E; Albuquerque M; Chabot JG; Moyse E; Chauvin JP; Aubert I; McLaurin J; Quirion R
    J Alzheimers Dis; 2012; 29(2):293-308. PubMed ID: 22232004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer's disease diagnosis.
    Murakami K; Tokuda M; Suzuki T; Irie Y; Hanaki M; Izuo N; Monobe Y; Akagi K; Ishii R; Tatebe H; Tokuda T; Maeda M; Kume T; Shimizu T; Irie K
    Sci Rep; 2016 Jul; 6():29038. PubMed ID: 27374357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
    Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
    FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
    Koh SH; Noh MY; Kim SH
    Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.